Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218452 · ClinicalTrials.gov registry record · Early Phase 1
Smoking Cessation for Young Adults Who Binge Drink - 1
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 41
- Enrollment target
NCT00218452: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT00218452 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 41 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (23% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00218452, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is develop and test the success of a new smoking cessation intervention that includes a component to eliminate binge drinking.
Primary Outcome
quantified as the percentage of sessions attended, will be summarized separately for each treatment group and compared between groups using the rank sum test. One summary will be performed for the percentage of sessions attended face-to-face and a second summary will be performed for the percentage of sessions attended either face-to-face or via telephone.
Interventions
- BEHAVIORAL Lifestyle counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-04 |
| Phase | Early Phase 1 |
What the finished NCT00218452 record still lists
NCT00218452 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (23% lower).
The record links to 0 conditions, and to 1 intervention - of which Lifestyle counseling is the first listed.
NCT00218452 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00218452 about?
NCT00218452 is a clinical study titled "Smoking Cessation for Young Adults Who Binge Drink - 1". The purpose of this study is develop and test the success of a new smoking cessation intervention that includes a component to eliminate binge drinking.
What is the current status of trial NCT00218452?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 41 participants. The study started on 2005-09. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00218452?
The interventions under investigation include: Lifestyle counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00218452?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00218452's enrollment target sits among peer trials
41 623rd of 2000 higher than 1,373 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia